COVID-19 and Clinical Trials: The Medidata Perspective
COVID-19 and Clinical Trials:
The Medidata Perspective
As COVID-19 has spread, we have been monitoring its global impact on clinical trials. We see the profound impact on our industry, both at a global level but also at the site level. Understanding what is happening on the ground is critical to define a path forward. Sharing this data is an important step, but it’s a first step. We will continue to publish updated analyses on overall industry trends throughout this pandemic and beyond.